Jiangxi Yuean Advanced Materials Co.,Ltd. (688786.SS)
Ganzhou, CN
Jiangxi Yuean Advanced Materials Co.,Ltd. primarily manufactures sophisticated metal powders and various membrane materials. Its comprehensive activities span the research, development, production, and distribution of a wide array of specialized products. These include crucial components such as carbonyl iron powder, magnetic material powder, atomized alloy powder, metal injection molding (MIM) feed, carbon nanotubes, advanced 3D printing alloy powder, and microwave absorbing materials. This enterprise was established in 2004 and has its headquarters situated in Ganzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.48% | +7.18% | +24.96% | +5.23% | +37.69% | +37.54% | +74.38% | +50.21% | -11.60% | -11.60% | -11.60% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.7% Q1'26: +15.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+18.4% ★ Q1'26: +8.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+26.6% ★ Q1'26: -0.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+22.9% ★ Q1'26: +20.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+10.7% ★ Q1'26: +9.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%0.0% Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.45× ★ Q1'26: 1.82× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
403.07M
est: 422.68M (-4.6%)
|
427.66M
est: 493.77M (-13.4%)
|
368.48M
est: 509.00M (-27.6%)
|
417.78M
est: 567.00M (-26.3%)
|
437.53M
est: 447.49M (-2.2%)
|
618.53M
618.53M – 618.53M
+38.2% YoY
|
780.34M
780.34M – 780.34M
+26.2% YoY
|
| EBITDA |
121.72M
est: 121.96M (-0.2%)
|
123.54M
est: 142.47M (-13.3%)
|
110.02M
est: 146.86M (-25.1%)
|
112.82M
est: 166.62M (-32.3%)
|
135.56M
est: 131.50M (+3.1%)
|
181.76M
181.76M – 181.76M
+38.2% YoY
|
229.31M
229.31M – 229.31M
+26.2% YoY
|
| EBIT |
105.66M
est: 99.78M (+5.9%)
|
108.74M
est: 116.57M (-6.7%)
|
90.42M
est: 120.16M (-24.8%)
|
77.27M
est: 133.28M (-42.0%)
|
100.00M
est: 105.19M (-4.9%)
|
145.39M
145.39M – 145.39M
+38.2% YoY
|
183.42M
183.42M – 183.42M
+26.2% YoY
|
| Net Income |
88.68M
est: 74.46M (+19.1%)
|
98.80M
est: 88.65M (+11.4%)
|
79.88M
est: 94.67M (-15.6%)
|
70.29M
est: 178.66M (-60.7%)
|
82.82M
est: 105.32M (-21.4%)
|
128.63M
128.63M – 128.63M
+22.1% YoY
|
162.94M
162.94M – 162.94M
+26.7% YoY
|
| SGA |
30.28M
est: 17.50M (+73.0%)
|
31.25M
est: 20.45M (+52.8%)
|
36.79M
est: 21.08M (+74.5%)
|
36.84M
est: 43.41M (-15.1%)
|
20.37M
est: 34.26M (-40.5%)
|
47.35M
47.35M – 47.35M
+38.2% YoY
|
59.74M
59.74M – 59.74M
+26.2% YoY
|
| EPS |
0.74
est: 0.63 (+18.4%)
|
0.69
est: 0.74 (-7.3%)
|
0.56
est: 0.79 (-29.5%)
|
0.49
est: 1.25 (-60.8%)
|
0.58
est: 0.55 (+5.5%)
|
0.90
0.90 – 0.90
+63.6% YoY
|
1.14
1.14 – 1.14
+26.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-25 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bing Wang | GM, Deputy Chief Engineer & Director | — | male |
| Bo Li | Chief Financial Officer, Secretary of the Board, Accounting Supervisor, Deputy Chief Engineer & Director | — | male |
| Shangkui Li | Chairman of the Board & Chief Engineer | — | male |
| Yan Song | Chairman of the Supervisory Board & Director of Audit Department | — | female |
| Yumei Chen | Director of Human Resources Department & Employee Representative Supervisor | — | female |
| Yunbao Yu | Assistant to the GM, Deputy Chief Engineer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688786.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
